This study is designed to monitor the safety of Boostagen® after it has been approved for use in Thailand. The study follows people who receive the vaccine in routine medical practice to identify and record any side effects.
Doctors, nurses, and other healthcare professionals from hospitals and clinics in central, eastern, southern, and northern Thailand take part in the study. They report any health problems that occur after vaccination using standard reporting forms.
The information collected helps researchers understand how safe the vaccine is when used in a large and diverse population under real-world conditions.
Primary objective: To describe the post-licensure safety profile of Boostagen® in Thailand.
Secondary objective: To identify any unexpected safety signals following vaccination with Boostagen®.